(Q43806941)

27 November 2017

Potent inhibition of cytokine production from intestinal lamina propria T cells by phosphodiesterase-4 inhibitory thalidomide analogues (English)

1 reference

27 November 2017

0 references

6

S R Targan

1 reference

27 November 2017

J L Prehn

1

1 reference

27 November 2017

C Landers

2

1 reference

27 November 2017

G W Muller

3

1 reference

27 November 2017

H W Man

4

1 reference

27 November 2017

D I Stirling

5

1 reference

27 November 2017

1 September 2001

1 reference

Journal of Clinical Immunology

27 November 2017

1 reference

27 November 2017

21

1 reference

27 November 2017

357-364

1 reference

27 November 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1012292703871

27 November 2017

0 references

cites work

Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset

1 reference

12 December 2020

A role for TNF-alpha and mucosal T helper-1 cytokines in the pathogenesis of Crohn's disease

1 reference

12 December 2020

Mucosal T cells provide helper function but do not proliferate when stimulated by specific antigen in lymphogranuloma venereum proctitis in nonhuman primates

1 reference

12 December 2020

The antidepressant rolipram suppresses cytokine production and prevents autoimmune encephalomyelitis

1 reference

12 December 2020

Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes

1 reference

12 December 2020

An open-label pilot study of low-dose thalidomide in chronically active, steroid-dependent Crohn's disease.

1 reference

12 December 2020

Thalidomide therapy for patients with refractory Crohn's disease: an open-label trial.

1 reference

12 December 2020

A short-term study of chimeric monoclonal antibody cA2 to tumor necrosis factor alpha for Crohn's disease. Crohn's Disease cA2 Study Group.

1 reference

12 December 2020

Mucosa-specific targets for regulation of IFN-gamma expression: lamina propria T cells use different cis-elements than peripheral blood T cells to regulate transactivation of IFN-gamma expression

1 reference

12 December 2020

Definition of a lamina propria T cell responsive state. Enhanced cytokine responsiveness of T cells stimulated through the CD2 pathway.

1 reference

12 December 2020

Specific type IV phosphodiesterase inhibitor rolipram mitigates experimental colitis in mice

1 reference

12 December 2020

In situ expression of interleukin-10 in noninflamed human gut and in inflammatory bowel disease

1 reference

12 December 2020

Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease

1 reference

12 December 2020

Differential cytokine modulation and T cell activation by two distinct classes of thalidomide analogues that are potent inhibitors of TNF-alpha

1 reference

12 December 2020

Inhibition of IL-12 production by thalidomide

1 reference

12 December 2020

Regulation of immune responses of the intestinal mucosa

1 reference

12 December 2020

T cells in inflammatory bowel disease: protective and pathogenic roles.

1 reference

12 December 2020

Thalidomide analogs and PDE4 inhibition

1 reference

12 December 2020

Selection of novel analogs of thalidomide with enhanced tumor necrosis factor alpha inhibitory activity

1 reference

12 December 2020

Transgenic expression of IL-10 in T cells facilitates development of experimental myasthenia gravis

1 reference

12 December 2020

Structural modifications of thalidomide produce analogs with enhanced tumor necrosis factor inhibitory activity

1 reference

12 December 2020

Thalidomide as an emerging immunotherapeutic agent

1 reference

12 December 2020

Inflammatory cytokines enhance the in vivo clonal expansion and differentiation of antigen-activated CD4+ T cells.

1 reference

12 December 2020

In vitro effects of oxpentifylline on inflammatory cytokine release in patients with inflammatory bowel disease

1 reference

12 December 2020

Treatment of Crohn's disease with anti-tumor necrosis factor chimeric monoclonal antibody (cA2).

1 reference

12 December 2020

Regulation of interferon-gamma mRNA in a cytolytic T cell clone: Ca(2+)-induced transcription followed by mRNA stabilization through activation of protein kinase C or increase in cAMP.

1 reference

12 December 2020

Identifiers

DOI

10.1023/A:1012292703871

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference